BiotechTube

Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation

ApprovedCompleted
0 watching 0 views this week🔥 Hot
80
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Dry Eye Syndromes

Conditions

Dry Eye Syndromes

Trial Timeline

Aug 1, 2020 → Jul 1, 2021

NCT ID
NCT04413279

About Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation

Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation is a approved stage product being developed by Ocular Therapeutix for Dry Eye Syndromes. The current trial status is completed. This product is registered under clinical trial identifier NCT04413279. Target conditions include Dry Eye Syndromes.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT04413279ApprovedCompleted

Competing Products

20 competing products in Dry Eye Syndromes

See all competitors
ProductCompanyStageHype Score
NEX-18a injection + Azacitidine InjectionNanexa ABPhase 1
28
GTB-3550 TriKE® Phase I + GTB-3550 TriKE® Phase IIGT BiopharmaPhase 1/2
33
clopidogrel + prasugrelDaiichi SankyoPhase 1
33
Triple oral lipid lowering treatmentDaiichi SankyoPhase 3
77
Placebo + PrasugrelDaiichi SankyoPhase 3
77
decitabine + azacitidineEisaiApproved
85
Galunisertib + PlaceboEli LillyPhase 2/3
65
TP-0184Sumitomo PharmaPhase 1/2
41
Epoetin alfaJohnson & JohnsonPhase 2
52
Placebo + Epoetin alfa + Placebo + Epoetin alfaJohnson & JohnsonPhase 3
77
BortezomibJohnson & JohnsonPhase 1/2
41
Azacitidine + VenetoclaxAbbViePhase 1
33
Venetoclax + Azacitidine + Cytarabine + Methotrexate + Hydrocortisone + Leucovorin + Dexamethasone + Vincristine + Doxorubicin + Dexrazoxane + Calaspargase Pegol + Erwinia asparaginaseAbbViePhase 1
33
venetoclax + azacitidineAbbViePhase 1
33
rosuvastatin calcium + atorvastatinAstraZenecaPhase 3
77
Ticagrelor + ClopidogrelAstraZenecaApproved
85
Ferric Carboxymaltose Injection [Ferinject]AstraZenecaApproved
85
Metoprolol + metoprolol plus morphineAstraZenecaApproved
85
Hydroxypropylmethylcellulose + CarboxymethylcelluloseMerckApproved
85
PembrolizumabMerckPhase 1
33

Other Products from Ocular Therapeutix

Dextenza + Prednisolone AcetateApproved
80
Dextenza 0.4Mg Ophthalmic Insert + Prednisolone AcetateApproved
80
Dexamethasone ophthalmic insert 0.4Mg + 0.2% loteprednol etabonate ophthalmic suspension + olopatadine hydrochloride ophthalmic solution 0.7%Approved
80
Omidria + Dextenza (dexamethasone ophthalmic insert) 0.4mg + Dexycu, 9% Intraocular Suspension + Prednisolone Acetate 1%Approved
80
Dextenza 0.4Mg Ophthalmic InsertApproved
80